
Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Patient Satisfaction and Clinical Efficacy of Novel Blood Glucose Meters Featuring Color Range Indicators in Patients With Type 2 Diabetes: A Prospective Study. International Organization for Standardization, Geneva, Switzerland, 2013. In vitro diagnostic test systems –requirements for blood‐glucose monitoring systems for self‐testing in managing diabetes mellitus (ISO 15197). International Organization for Standardization. CONTOUR ®NEXT ONE BGMS User Guide Rev 08/19. Poster presented at the 78th Scientific Session of the American Diabetes Association (ADA) June 22‐26, 2018 Orlando, Florida. User Experience With the Information–Motivation–Behavioral Skills (IMB)–Based CONTOUR ®NEXT ONE Smart Meter and App System. Poster presented at the 20th Annual Diabetes Technology Meeting (DTM) November 12-14, 2020.

#CONTOUR NEXT ONE BATTERY FULL#
For a full list of compatible mobile operating systems, visit .ġ.
#CONTOUR NEXT ONE BATTERY PROFESSIONAL#
†Always consult your healthcare professional before setting or changing any target ranges. #Before use see the CONTOUR ®NEXT ONE user guide for full instructions. 99% of individual glucose measured values need to fall within zones A and B of the Consensus Error Grid (CEG) for type 1 diabetes. Ƒ95% of the measured glucose values needed to fall within either ☑5 mg/dL (☐.83 mmol/L) of the average measured values of the reference measurement procedure at glucose concentrations <100 mg/dL (<5.55 mmol/L) or within ☑5% at glucose concentrations ≥100 mg/dL (≥5.55 mmol/L).
